[Form 4] Dolby Laboratories, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Dolby Laboratories SVP, Entertainment John D. Couling reported multiple stock transactions in Dolby Laboratories, Inc. Class A Common Stock. On May 4–5, 2026, he sold a total of 12,354 shares in open-market transactions at weighted average prices around $57–$58 per share.
On the same date, he also exercised employee stock options covering 7,666 shares at an exercise price of $45.50 per share. A footnote states that shares held following these transactions include 55,114 shares underlying restricted stock units that remain subject to forfeiture until they vest.
The sales were executed in multiple trades within disclosed price ranges and were carried out under a Rule 10b5-1 trading plan adopted on February 3, 2026, indicating they were pre-scheduled rather than discretionary market-timing decisions.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 7,666 | $0.00 | -- |
| Exercise | Class A Common Stock | 7,666 | $45.50 | $349K |
| Sale | Class A Common Stock | 6,928 | $57.4708 | $398K |
| Sale | Class A Common Stock | 738 | $58.3354 | $43K |
| Sale | Class A Common Stock | 4,688 | $58.465 | $274K |
Footnotes (1)
- Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. The shares were sold in multiple transactions at prices ranging from $57.16 to $58.05 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026. The shares were sold in multiple transactions at prices ranging from $58.195 to $58.36, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026. This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.